Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Pharmacokinetics, Relative Bioavailability and Safety of Xaracoll Implant

ClinicalTrials.gov ID: NCT02232178

Public ClinicalTrials.gov record NCT02232178. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 2:14 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Blinded, Inpatient Study to Investigate the PK, Relative Bioavailability and Safety of 2 Doses of XaraColl (200 and 300 mg Bupivacaine HCl) Compared to Bupivacaine HCl Infiltration (150 mg) After Open Laparotomy Hernioplasty

Study identification

NCT ID
NCT02232178
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Innocoll
Industry
Enrollment
64 participants

Conditions and interventions

Conditions

Interventions

  • 2 100mg Xaracoll implants Drug
  • 3 100mg Xaracoll implants Drug
  • 150mg Bupivacaine HCl injection Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 19, 2014
Primary completion
Feb 22, 2015
Completion
Mar 22, 2015
Last update posted
Oct 19, 2020

2014 – 2015

United States locations

U.S. sites
5
U.S. states
3
U.S. cities
5
Facility City State ZIP Site status
Pinnacle Research Group Anniston Alabama 36207
Shoals Medical Trials Sheffield Alabama 35660
Wexner Medical Center at Ohio State University Columbus Ohio 43210
First Surgical Hospital Bellaire Texas 77401
Victory Hospital Houston Texas 77704

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02232178, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 19, 2020 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02232178 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →